A study of French-Canadian cancer families suggested that women with breast cancer before the age of 50 with no family history of cancer still warrant screening for TP53 mutations, even though the mutation frequency (0.5%) is low compare to BRCA mutations (4.8%) [28]. Here, TP53 is linked to breast cancer.